Nicast announces plans to launch NovaMesh Intra-abdominal hernia
mesh in Europe in 2010
9 December 2009
Israeli company Nicast, developer of medical devices made of
electrospun nanofabric, has announced it is readying to launch the
NovaMesh intra-abdominal hernia mesh in the European market in Q1 2010,
pending European regulatory approval.
NovaMesh is the first intra-abdominal hernia mesh to utilize the special
properties of electrospun nanofabric.
“In preclinical animal studies, NovaMesh has demonstrated excellent
resistance to adhesions on the organ facing surface followed by regrowth
of the peritoneum, strong tissue integration on the abdominal facing
surface, and minimal mesh shrinkage,” stated Nicast CEO Benjamin Eliason.
The findings of the preclinical study of the NovaMesh will be announced
following the receipt of the final study report.
AVflo is a self-sealing vascular access graft that enables
unobstructed blood flow, allows for dialysis within 24-48 hours after
implantation and self-seals within less than five minutes following
withdrawal of the dialysis needles. The AVflo received CE certification
in October 2008. The Company plans to introduce the improved version of
the AVflo vascular access graft to the European market in the first
quarter of 2010.
“Nicast is strengthening its production capabilities in order to meet
the anticipated market demand for both the NovaMesh and the improved
AVflo. We continue to actively build our distribution base noting the
high enthusiasm emerging from our discussions with distributors
throughout Europe. We are looking forward to speaking with additional
potential partners at Medica,” said Mr. Eliason.